Vascular Endothelial Growth Factor Inhibitor [EPC]

20 drugs in this class with 880,672 total adverse event reports.

20 Drugs

880,672 Total Reports

435,246 Serious Reports

174,659 Death Reports

#	Drug Name	Generic Name	Reports	Serious	Deaths
1	Bevacizumab	BEVACIZUMAB	120,853	52,978	27,863
2	Paclitaxel	PACLITAXEL	95,861	50,663	15,996
3	Capecitabine	CAPECITABINE	90,021	39,515	18,161
4	Paclitaxel (Aibumin-Bound)	PACLITAXEL (AIBUMIN-BOUND)	79,282	43,516	11,097
5	Fluorouracil	FLUOROURACIL	75,128	33,864	10,682
6	Fluorouracil Cream, 0.5%	FLUOROURACIL CREAM, 0.5%	74,062	33,499	10,606
7	Oxaliplatin	OXALIPLATIN	71,866	36,751	10,538
8	Atezolizumab	ATEZOLIZUMAB	37,421	22,926	9,568
9	Cetuximab	CETUXIMAB	30,786	9,631	4,188
10	Aflibercept	AFLIBERCEPT	30,608	16,469	8,871
11	Osimertinib	OSIMERTINIB	30,472	24,279	13,492
12	Ranibizumab	RANIBIZUMAB	26,273	7,764	5,088
13	Temozolomide	TEMOZOLOMIDE	20,653	10,277	4,341
14	Olaparib	OLAPARIB	20,092	15,002	5,804
15	Leucovorin	LEUCOVORIN CALCIUM	18,512	9,758	2,480
16	Panitumumab	PANITUMUMAB	14,906	6,412	2,467
17	Irinotecan	IRINOTECAN HYDROCHLORIDE	12,343	6,637	2,545
18	Regorafenib	REGORAFENIB	11,442	4,943	2,347
19	Trifluridine / Tipiracil	TRIFLURIDINE AND TIPIRACIL	10,494	5,148	4,196
20	Erlotinib	ERLOTINIB	9,597	5,214	4,329